Therapeutic Solutions International, Inc. (TSOI)

USD 0.0

(0.0%)

Revenue Summary of Therapeutic Solutions International, Inc.

  • Therapeutic Solutions International, Inc.'s latest annual revenue in 2023 was 98.99 Thousand USD , down -52.12% from previous year.
  • Therapeutic Solutions International, Inc.'s latest quarterly revenue in 2024 Q2 was 20 Thousand USD , down -99.91% from previous quarter.
  • Therapeutic Solutions International, Inc. reported a annual revenue of 206.76 Thousand USD in annual revenue 2022, up 41.66% from previous year.
  • Therapeutic Solutions International, Inc. reported a annual revenue of 145.95 Thousand USD in annual revenue 2021, up 132.86% from previous year.
  • Therapeutic Solutions International, Inc. reported a quarterly revenue of 20 Thousand USD for 2024 Q2, down -99.91% from previous quarter.
  • Therapeutic Solutions International, Inc. reported a quarterly revenue of 23.12 Thousand USD for 2023 Q1, up 169.53% from previous quarter.

Annual Revenue Chart of Therapeutic Solutions International, Inc. (2023 - 2007)

Historical Annual Revenue of Therapeutic Solutions International, Inc. (2023 - 2007)

Year Revenue Revenue Growth
2023 98.99 Thousand USD -52.12%
2022 206.76 Thousand USD 41.66%
2021 145.95 Thousand USD 132.86%
2020 62.68 Thousand USD 127.97%
2019 27.49 Thousand USD 689.18%
2018 3484.00 USD 22.2%
2017 2851.00 USD -43.08%
2016 5009.00 USD 162.11%
2015 1911.00 USD -99.29%
2014 268.89 Thousand USD -13.7%
2013 311.59 Thousand USD -85.78%
2012 2.19 Million USD 29.84%
2011 1.68 Million USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%

Peer Revenue Comparison of Therapeutic Solutions International, Inc.

Name Revenue Revenue Difference
Burzynski Research Institute, Inc. - USD -Infinity%
Arch Therapeutics, Inc. 75.72 Thousand USD -30.73%
Evofem Biosciences, Inc. 18.21 Million USD 99.457%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
Santhera Pharmaceuticals Holding AG 122.95 Million USD 99.919%
Qrons Inc. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
Neon Bloom, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 1.93 Million USD 94.876%
ProtoKinetix, Incorporated - USD -Infinity%
Skye Bioscience, Inc. - USD -Infinity%
Eiger BioPharmaceuticals, Inc. 15.77 Million USD 99.372%
Nanobac Pharmaceuticals, Incorporated 17.62 Thousand USD -461.796%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 21.47 Million USD 99.539%
Intellipharmaceutics International Inc. 65.72 Thousand USD -50.612%
Propanc Biopharma, Inc. - USD -Infinity%
Mesoblast Limited 5.9 Million USD 98.323%
Marizyme, Inc. 645.81 Thousand USD 84.671%
Genus plc 668.8 Million USD 99.985%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 99.96%
CNBX Pharmaceuticals Inc. 410.16 Thousand USD 75.865%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 76.76 Thousand USD -28.964%
IMV Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 39.51 Thousand USD -150.504%
MultiCell Technologies, Inc. 49.32 USD -200617.762%
ONE Bio Corp. 52.29 Million USD 99.811%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 49.72 Million USD 99.801%
Arno Therapeutics, Inc. - USD -Infinity%
EV Biologics, Inc. 48.9 Thousand USD -102.442%
Q BioMed Inc. 284.35 Thousand USD 65.186%
Emmaus Life Sciences, Inc. 29.59 Million USD 99.666%
Mosaic ImmunoEngineering Inc. - USD -Infinity%
Biomind Labs Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 145.09 Million USD 99.932%
Provectus Biopharmaceuticals, Inc. 557.71 Thousand USD 82.25%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Oncotelic Therapeutics, Inc. 70 Thousand USD -41.42%
GlobeStar Therapeutics Corporation - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. 658.5 Thousand USD 84.967%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. - USD -Infinity%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 14.69 Billion USD 99.999%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 999.00 USD -9809.309%
Enzolytics Inc. 52.79 Thousand USD -87.503%
Agentix Corp. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 608.52 Thousand USD 83.732%
MetaStat, Inc. - USD -Infinity%
argenx SE 1.22 Billion USD 99.992%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. 140.24 Thousand USD 29.412%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. 617.38 Thousand USD 83.966%
Zenith Capital Corp. - USD -Infinity%
Genscript Biotech Corporation 839.52 Million USD 99.988%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. - USD -Infinity%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Kadimastem Ltd - USD -Infinity%
Helix BioMedix, Inc. 997.72 Thousand USD 90.078%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 48.35 Million USD 99.795%
BioStem Technologies, Inc. 16.68 Million USD 99.407%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
Regen BioPharma, Inc. 236.56 Thousand USD 58.153%
Regen BioPharma, Inc. 236.56 Thousand USD 58.153%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. 1.36 Million USD 92.769%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
CytoDyn Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 473.73 Thousand USD 79.103%
SYBLEU INC 11.69 Thousand USD -746.392%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. - USD -Infinity%
International Stem Cell Corporation 7.78 Million USD 98.729%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 13 Thousand USD -661.492%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. - USD -Infinity%
Neutra Corp. 39.53 Thousand USD -150.402%
Windtree Therapeutics, Inc. - USD -Infinity%
PureTech Health plc 3.33 Million USD 97.027%
Coeptis Therapeutics, Inc. - USD -Infinity%
IXICO plc 6.66 Million USD 98.515%
IntelGenx Technologies Corp. 1.03 Million USD 90.472%
Gelesis Holdings, Inc. 25.76 Million USD 99.616%
CSL Limited 14.8 Billion USD 99.999%
Cellectis S.A. 755 Thousand USD 86.888%